Clinical Trial Update: Determination of Accuracy in Measurement of Total Immunoglobulin E Using a Test Device in Atopic Subjects [Phase 2]

View source ↗

Summary

Phase 2 study evaluating the accuracy of a total IgE measurement device in atopic subjects (atopic asthma); study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Asthma

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Atopic Asthma | Phase 2 | Status: COMPLETED